Las Vegas, NV, United States of America

Laurence R Meyerson

This inventor holds 21 USPTO granted patents and 26 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Neurological Treatments. Top assignees: Adamas Pharmaceuticals, Inc., Adamas Pharmaceutical, Inc., Adamas Pharmacueticals, Inc.. Active years: 2009-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laurence R Meyerson. Retrieved from https://idiyas.com/inventor/laurence-r-meyerson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 

% Patents Active = 100.0


 

Average Co-Inventor Count = 3.8

ph-index = 20

Forward Citations = 570(Granted Patents)


Location History:

  • Las Vegas, CA (US) (2013)
  • Las Vegas, NV (US) (2009 - 2015)

Company Filing History:


Years Active: 2009-2015

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Neurological Disease
CNS Conditions
NMDA Receptor Antagonist
Treatment Composition
Administration Method
Therapeutic Composition
Neurology
Pharmaceuticals
Disease Management
Clinical Applications
Composition Method
Neuropharmacology
21 patents (USPTO):Explore Patents

Title: Laurence R. Meyerson: A Pioneer in Neurological Disease Treatment

Introduction

Laurence R. Meyerson is an accomplished inventor based in Las Vegas, NV, known for his innovative contributions to the field of medicine, particularly in the treatment of neurological diseases. With a remarkable portfolio of 21 patents, Meyerson's work is recognized for its potential to improve therapeutic outcomes and patient care.

Latest Patents

Meyerson's latest patents focus on compositions and methods for treating neurological diseases. One notable patent discusses compositions comprising amantadine or its pharmaceutically acceptable salts, combined with excipients that modify the release of amantadine. This innovative method of administration aims to improve the pharmacokinetic profile of the drug, providing better management of plasma concentrations over time. Specifically, the method involves oral administration of a daily dose of 300 to 500 mg of amantadine to achieve a gradual change in plasma concentration, ensuring efficacy while minimizing side effects.

Career Highlights

Throughout his career, Laurence Meyerson has worked with notable companies, including Adamas Pharmaceuticals, Inc. and Adamas Pharmaceutical, Inc. His dedication to research and development in pharmaceuticals has led to significant advancements in treatment strategies for neurological conditions. His contributions to the field have garnered attention and respect from peers and industry leaders alike.

Collaborations

Meyerson has collaborated with distinguished professionals in the pharmaceutical and medical fields, including colleagues Gregory T. Went and Timothy J. Fultz. These collaborations have further enhanced the scope and impact of his innovative work, allowing for a more comprehensive approach to addressing complex neurological disorders.

Conclusion

Laurence R. Meyerson’s innovative spirit and commitment to addressing neurological diseases through his patent portfolio exemplify his role as a leading inventor in the medical field. His contributions not only advance treatment methodologies but also inspire future research and development efforts in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…